Baker Bros. Advisors LP Hookipa Pharma Inc. Transaction History

Baker Bros. Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.42 - $0.86 $26,356 - $53,967	62,753 Added 0.78%	8,128,151 $6.58 Million
Q3 2023 Nov 14, 2023	BUY	$0.58 - $0.91 $2.11 Million - $3.31 Million	3,639,863 Added 82.25%	8,065,398 $5 Million
Q2 2023 Aug 14, 2023	BUY	$0.71 - $1.97 $674,500 - $1.87 Million	950,000 Added 27.33%	4,425,535 $3.89 Million
Q4 2022 Feb 14, 2023	BUY	$0.73 - $14.6 $784,789 - $15.7 Million	1,075,054 Added 44.78%	3,475,535 $2.82 Million
Q1 2022 May 16, 2022	BUY	$1.26 - $2.52 $2.14 Million - $4.28 Million	1,700,000 Added 242.69%	2,400,481 $5.47 Million
Q1 2020 May 15, 2020	SELL	$5.9 - $13.8 $1.14 Million - $2.65 Million	-192,376 Reduced 21.55%	700,481 $5.78 Million
Q2 2019 Aug 14, 2019	BUY	$6.16 - $14.15 $5.5 Million - $12.6 Million	892,857 New	892,857 $6.01 Million

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $98.7M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.